Artigo Revisado por pares

SOME CENTRAL NERVOUS SYSTEM DRUGS DESIGNED FROM METABOLIC CONSIDERATIONS

1962; Wiley; Volume: 96; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1962.tb50126.x

ISSN

1749-6632

Autores

Rex Pinson, Barry M. Bloom, Christine Buck,

Tópico(s)

Diet and metabolism studies

Resumo

Annals of the New York Academy of SciencesVolume 96, Issue 1 p. 336-344 SOME CENTRAL NERVOUS SYSTEM DRUGS DESIGNED FROM METABOLIC CONSIDERATIONS Rex Pinson Jr., Rex Pinson Jr. Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this authorBarry M. Bloom, Barry M. Bloom Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this authorC. J. Buck, C. J. Buck Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this author Rex Pinson Jr., Rex Pinson Jr. Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this authorBarry M. Bloom, Barry M. Bloom Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this authorC. J. Buck, C. J. Buck Research Laboratories, Chas. Pfizer & Co., Inc., Groton, Conn.Search for more papers by this author First published: January 1962 https://doi.org/10.1111/j.1749-6632.1962.tb50126.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Trefouel, J., Mme. J. Trefouel, F. Nitti & D. Bovet. 1935. Compt. rend. soc. biol. 120: 756. CASGoogle Scholar 2 Burns, J. J., T. F. Yü, A. Ritterband, J. M. Perel, A. B. Gutman & B. B. Brodie. 1957. J. Pharmacol. Exptl. Therap. 119: 418. CASPubMedWeb of Science®Google Scholar 3 Albert, A. 1960. Selective Toxicity. Wiley. New York , N. Y. . Google Scholar 4 Nickerson, M. 1949. Pharmacol. Revs. 1: 27. Web of Science®Google Scholar 5 Nickerson, M. 1956. Federation Proc.. 15: 463. Google Scholar 6 Axelrod, J. 1954. J. Pharmacol. Exptl. Therap. 110: 315. CASPubMedWeb of Science®Google Scholar 7 Rowe, R. P., S. L. Lofgren & A. Kelley. 1961. Federation Proc.. 20: 396. Google Scholar 8 Brodie, B. B., S. Udenfriend & W. Dill. 1947. J. Biol. Chem. 168: 335. CASPubMedWeb of Science®Google Scholar 9 Keller, R. E. & W. C. Ellenbogen. 1952. J. Pharmacol. Exptl. Therap. 106: 77. CASPubMedWeb of Science®Google Scholar 10 Bloom, B. M., R. L. Wagner, C. S. Delahunt & E. C. Schrieber. 1959. Diseases of Nervous System.. 20: 10. Google Scholar 11 Beyer, K. H. & J. T. Skinner. 1940. J. Pharmacol. Exptl. Therap. 68: 419. CASWeb of Science®Google Scholar Citing Literature Volume96, Issue1Some Biological Aspects of Schizopherenic BehaviorJanuary 1962Pages 336-344 ReferencesRelatedInformation

Referência(s)